Clinical data | |
---|---|
Routes of administration | By mouth, nasal and sublingual |
ATC code |
|
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | >90% |
Metabolism | Liver |
Elimination half-life | 16–20 hours |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.525 |
Chemical and physical data | |
Formula | C18H21N |
Molar mass | 251.373 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Desoxypipradrol, also known as 2-diphenylmethylpiperidine (2-DPMP), is a drug developed by Ciba in the 1950s[1] which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI).[2]